Solution Selling Explained
Solution selling is a methodology that organises the sale around diagnosing a buyer’s business pain and then configuring an answer to it, instead of presenting a product and hoping it fits. It is among the oldest of the named approaches and the most commonly declared.
It is also the least commonly practised, and the reason is structural rather than a failure of effort. The method assumes the seller can change the shape of what is sold. Most sellers cannot. Remove that authority and what is left is a discovery call bolted onto a fixed demo, which is what a great deal of self-described practice actually amounts to.
Where solution selling came from
Frank Watts developed the method in 1975 and refined it at Wang Laboratories, where the products were systems sold to be fitted to a customer’s situation rather than items off a shelf. He began teaching it independently in 1982 and presented a workshop to Xerox that year. Mike Bosworth, out of his own Xerox experience, founded a training business under the same name in 1983, wrote Solution Selling: Creating Buyers in Difficult Selling Markets in 1994, and sold the intellectual property to Keith M. Eades in 1999.
The provenance is not trivia. The method was built for systems sales, where the thing being sold genuinely had to be assembled around the customer’s situation, and where the seller sat close enough to the people building it to do the assembling. Every assumption in the method comes from that setting: that there is a real problem to diagnose, that the answer is not predetermined, and that the seller has room to move.
Where those conditions still hold, it still works, and it works well. Where they do not, it was never going to, and no amount of training will install a behaviour the organisation has made impossible.
What solution selling actually requires
Three preconditions. Miss any one of them and you are doing something else with the vocabulary attached.
A configurable offering. There has to be more than one available answer, and the differences between them have to matter to the buyer. One product, one edition, one price means diagnosis cannot change the outcome, so it is decoration. Configurable does not have to mean bespoke. Three implementation shapes, two service levels and a real choice about sequencing is enough, provided the choice is the buyer’s to make and provided it is made on evidence.
A seller with the authority to configure. This is the one that quietly fails. A rep who identifies exactly what the buyer needs, then submits it to a pricing desk that returns the standard package, has learned something they cannot act on. Twice through that loop and they stop asking.
A buyer who can name the pain. The method starts downstream of problem recognition. It does not create recognition, it works with it.
The diagnostic work itself has a name: tracing the pain chain. You begin with the person in front of you, establish what their current situation costs them specifically, then follow it outward. Who else is affected when it happens. Who hears about it. Whose number moves when it is fixed. The point is not sympathy. It is finding the person whose pain is large enough to fund a decision, because the person feeling the symptom is very often not the person who signs.
A question structure helps, and SPIN is the most durable of them, mainly because it makes the consequence question explicit rather than optional.
Why did solution selling decay into “ask a few questions, then demo”?
Because every force acting on a sales team pushes in that direction, and nothing pushes back unless a manager makes it.
Diagnosis is slow and uncounted; the demo is fast and counted. Tracing a pain chain across four stakeholders takes weeks and produces nothing a Friday pipeline review can display. A booked demo produces a line in a report the same afternoon. Given a quota and a weekly forecast, sellers do the countable thing, which is a correct response to what they are measured on.
The CRM turned pain into a field. Once “business pain” is a required text box before a deal can advance a stage, the job changes from diagnosing to filling. The box gets something plausible typed into it on the way to the next stage, and then the field’s existence is taken as evidence that diagnosis happened. Nobody reads it again.
Pain-to-product mapping trains the wrong reflex. Enablement material listing the pains your product addresses is genuinely useful, and it has a side effect: sellers learn to recognise those pains and stop looking once they find one. Discovery shaped to confirm what you already sell is not diagnosis. It is qualification in a diagnosis costume, and buyers can hear the difference.
The authority went away. Standardised packaging and centralised pricing made businesses easier to run and audit, and they removed the seller’s room to configure. The method’s central act became something the seller was no longer permitted to perform, so the surviving parts were the questions, which cost nothing to keep.
None of these is a character flaw. They are four defensible decisions that happen, together, to dismantle the thing.
Solution selling vs consultative selling
These two get separated by temperament, with consultative cast as the relationship one and this as the problem-solving one. That distinction is useless, because no manager can coach to it. Three operational differences are real.
Where the diagnostic burden sits. This method assumes the buyer arrives with a recognised pain, and takes responsibility for sizing it and configuring an answer. Consultative selling takes responsibility for the diagnosis itself, including the possibility that the problem the buyer stated is not the one that matters. Our guide to consultative selling sets out what that discipline actually demands.
What is allowed to come out of the process. In consultative selling, “do not buy this” has to be genuinely available or the diagnosis is theatre. The older method is more comfortable assuming a purchase will happen and treating the open question as which one. That is not dishonesty, it is a narrower remit, and a narrower remit is cheaper to run.
What it costs the buyer. Diagnostic rigour spends the buyer’s time. When the buyer already knows what hurts and has known for a year, that time reads as delay, and the seller asking a fifth situation question is charging them for work already done. Most organisations sell into both states at once, which is why forcing one approach across a whole portfolio loses money in two directions.
So they are less rivals than tools with different starting assumptions. Pick by where your buyers actually are when they reach you, not by which one sounds more principled in a training room.
Is solution selling dead?
No. It is conditional on the buyer’s state, and the argument that it is dead describes one of those states accurately. The claim has a specific origin worth knowing. In “The End of Solution Sales”, published in the July-August 2012 issue of Harvard Business Review, Brent Adamson, Matthew Dixon and Nick Toman argued that customers no longer need sellers the way they used to, because procurement teams and purchasing consultants can now define their own solutions without help.
On its own terms that is a fair description of a real buyer, and it is worth reading before arguing with. The correction is that it describes one buyer state rather than the market, and the difference turns on something the argument passes over quickly: naming a pain is not the same as writing a specification.
Three states, and the method is worth a different amount in each.
The buyer has not recognised a problem. There is nothing to start from. Something has to create the insight first, which is what the Challenger model was built to do.
The buyer has named the pain but cannot specify the answer. This is home ground, and it is efficient here. They know what hurts, they do not know what good looks like, and they want the configuration done with them rather than to them.
The buyer has named the pain and written the specification. This is the state the 2012 argument describes. Diagnosis adds nothing, the conversation is a procurement, and you compete on terms, risk and delivery. Insisting on discovery here does not make you thorough. It makes you slow.
When is solution selling the wrong choice?
Four conditions: nothing configurable, no recognised problem, conflicting pains across stakeholders, or a pain you were trained to find. Check the first before any of the others, because it is the one that quietly invalidates the rest.
Nothing is genuinely configurable. One product, one edition, one price. Run a straightforward transactional sale and let the buyer get on with their day.
The buyer does not yet know they have a problem. Diagnosing a pain nobody has admitted to reads as an interrogation, and the buyer’s defence is to end the meeting politely.
Six stakeholders hold conflicting pains. The method handles one pain chain well. A consensus purchase where operations wants speed and finance wants a cost line to stop growing is a different shape of problem, and solving hard for one stakeholder’s pain can actively manufacture an opponent in the room you are not in.
The only pain you can find is one you were trained to find. If the diagnosis always lands on something you happen to sell, it is not diagnosis. Our guide to choosing a sales methodology covers how to make that judgement across a portfolio rather than one deal at a time.
Frequently asked questions
What is solution selling?
A methodology built on diagnosing the buyer’s business pain, tracing who else it affects and what it costs, then configuring an answer to it. It starts from a pain the buyer has already recognised, and it assumes the seller can change the shape of what is sold.
Who invented solution selling?
Frank Watts developed it in 1975 and refined it at Wang Laboratories, teaching it independently from 1982. Mike Bosworth founded a training business of the same name in 1983 and published Solution Selling: Creating Buyers in Difficult Selling Markets in 1994.
What is the difference between solution selling and product selling?
Product selling leads with what the product does and looks for a buyer it fits. The other leads with what the buyer’s current situation costs and configures from there. The practical test is whether the outcome of discovery ever changes what gets proposed. If it never does, you are product selling with extra questions.
What is a pain chain?
The path a problem travels through an organisation. You establish what the current situation costs the person in front of you, then follow it to who else is affected and whose numbers move when it is fixed. It matters because the person feeling the symptom is rarely the person who signs, and a pain that stops at one desk rarely clears a budget.
Is solution selling still relevant?
Yes, under conditions. It works well when the buyer has named the pain but has not yet specified the answer, and when you can genuinely configure what you sell. It adds little once the buyer has written the specification, and it has nothing to work with when they have not recognised a problem at all.
The endgame is where training shows
Anyone can deliver a presentation. The difference between sales professionals often appears late in the deal—when they must distinguish a genuine process delay from a soft no, navigate objections, negotiate value, and ask the questions that move a decision forward.
Master Modern Sales: Ethical, Buyer-Centric Strategies for High Performance Professionals is the official online exam-preparatory course for the SMEI Certified Professional Salesperson (SCPS™) designation. The self-paced program goes well beyond closing techniques, covering buyer behavior, communication, prospecting, sales planning, consultative selling, negotiation and objection handling, account management, sales technology, strategic selling, and ethical professional practice.
The course includes online video instruction, chapter-based learning resources, quizzes, and a practice exam, giving sales professionals a structured way to strengthen their skills while preparing for the SCPS™ certification exam.
If you want to become more deliberate about how you sell—not simply how you close—start with Master Modern Sales.